In most instances, detection of drug resistant TB is delayed due to the limited availability of good diagnostic services. This perpetuates a cycle of TB transmission. By the time an infected patient is diagnosed, one might have visited several doctors and in the process may have infected many others with drug resistant strains of TB. To prevent drug resistance, it is vital to ensure treatment adherence and access to quality medication. Many patients do not adhere to the prescribed TB drug regimens, which in turn promotes resistance. Experts from the TB field are of the opinion that the number may be grossly underestimated and testing for drug resistance at the outset is the way forward. The WHO has developed newly adopted sustainable goals for ending the TB epidemic by 2030 and is also making new guidelines to help curb new forms of drug-resistant tuberculosis.